NASDAQ Move Aggressively on First Friday of 2013 (FOLD, ARAY, SIMG, DNDN, OREX)

New York, NY -- (SBWIRE) -- 01/04/2013 -- Amicus Therapeutics, Inc. (NASDAQ:FOLD) Amicus Therapeutics Inc. is showing bullish pre-market activity as the company announced positive results from all Cohorts in Phase 2 Chaperone-Enzyme Replacement Therapy Co-Administration Study for Pompe Disease. Trading at an intraday of $3.75 (+13.64%) with over 1.5 million shares that have exchanged hands, will FOLD continue to push to $4 and further? Stick around.

Accuray Incorporated (NASDAQ:ARAY) Accuray Incorporated fell on early trading due to JPMorgan downgrading the company from Neutral to Underweight. Trading at an intraday of $5.14 (-24.19%) with over 3.8 million shares exchanged, will ARAY continue to push back? Stick around.

Silicon Image, Inc. (NASDAQ:SIMG) Silicon Image Inc. lowered their Q4 revenue guidance, trading at an intraday of $4.60 (-10.85%) with over 850,000 shares traded, will SIMG continue to fall or bounce back? Stick around.

Dendreon Corporation (NASDAQ:DNDN) Dendreon Corp. has been on a bullish trend since early November, trading at an intraday of $6.15 (+6.17%) with over 2.1 million shares that have exchanged hands, will DNDN continue on its bullish momentum? Stick around.

Orexigen Therapeutics, Inc. (NASDAQ:OREX) Orexigen Therapeutics Inc. is has been on a bullish trend since mid November, trading at an intraday of $6.295 (8.16%) with over 1.1 million shares exchanged, will OREX continue to push towards the end of day? Stick around.

View Full NASDAQ Report: http://toonicestocks.com/news/2799-nasdaq-move-aggressively-first-friday-2013-fold-aray-simg-dndn-orex

About TooNiceStocks.com
Sign up now for free weekly technical and research reports. Read our daily popular speaking research blogs. We work hard in researching companies in all exchanges. Please add us on Twitter http://www.twitter.com/toonicestocks or like us on

Facebook http://www.facebook.com/pages/TooNiceStocks/243228112357605?ref=ts Real Research for Real Investors.

None of the companies mentioned by TooNiceStocks.com in our daily market research blogs, constitutes a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor. TooNiceStocks.com in no way has been compensated for advertising, marketing or profiling any of these companies, rather we have initiated our own independent research. The data stated in our research blog is derived from publicly disseminated information. Examples presented on TooNiceStocks.com website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments as these are our own opinions. Please note well that TooNiceStocks.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever.